Today's New Buy Pick - Mesoblast Limited (MESO)

China and the U.S. have just 10 days to finalize a phase one trade deal before additional U.S. tariffs on $156 billion worth of Chinese goods go into effect. Yesterday’s reports  that, harsh rhetoric aside, both countries were moving forward with  negotiations and President Donald Trump saying that talks were going  “very well” lifted sentiment around the trade deal, helping the market  snap a three-day losing streak... [Dollar General]( shares are trading higher  this morning after the discount retailer posted better-than-expected  earnings and raised its full-year forecast. The dollar store operator  reported earnings per share of $1.42, compared to analysts’ estimates  for earnings per share of $1.38. “We are pleased with another quarter of  strong performance across the business,” said Dollar General CEO Todd Vasos...    [Read More]( [$17M System Releases its Next Pick on this Free Broadcast]( Roger's "Overnight Fortune" stock picks have been 8X more profitable than buy Amazon in 1997, turning a tiny $3k model portfolio into over $17M. And he's about to give you the ticker symbol of its next pick...(ad) [Access the Broadcast Here](   - [Stock Market algorithm makes shockingly accurate predictions]( - A software expert has created an algorithm that detects stock market trends with shocking accuracy. It's creator, Tom Gentile, is giving common people who are invested (or interested in investing) in the stock market, a rare chance to access the recommendations he finds using this system. A system which allows you to circle a date on a calendar, and know, with at least 90% certainty, that you could cash in on that day. (ad) [Learn all the details here.](  [Trade delay is probably bad news for cyclicals like CSX]( Volatility has returned to the market since the Thanksgiving break; the  expectation of a trade deal between the U.S. and China was countered at  the beginning of this week with a contradictory statement from President  Trump, who said that it might be better to delay a trade deal until  after the 2020 election. Keeping trade tensions front and center for the  better part of another year hardly seems like a recipe to give  investors reason to be bullish, especially as concerns seem to be  mounting that tariffs are eroding not only corporate profits on a global  scale but also starting to wear down consumer confidence. [Read More](  [Finally! How to Buy and Sell Critical Turning Points In Any Stock]( Emotions are the single biggest reason investors lose money. This proven investing system can help you stop losing money and profit from the biggest trends. Now you can quickly build a large nest egg that never runs out. [ad] [Take control of your financial future and start winning in the market right now.]( Featured Stock [Mesoblast Limited (MESO) Buy Target – $6.40 or Better]( Mesoblast Limited, a biopharmaceutical company, develops and   commercializes allogeneic cellular medicines. The company offers   products in the areas of cardiovascular, spine orthopedic disorder,   oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on   specialized cells known as mesenchymal lineage adult stem cells. The   company’s products under the Phase III clinical trials include   MSC-100-IV for steroid refractory acute graft versus host disease;   MPC-150-IM for advanced heart failure; and MPC-06-ID for chronic low   back pain due to degenerative disc disease.  Other Top Stories [Market Buy/Sell Ratio at a flat 1.05]( [US long-term mortgage rates steady; 30-year loan at 3.68%]( [Holiday money-saving strategies that can backfire]( [Stocks fall in early trading as investors wait on trade](  Sponsor [$12.3 Trillion on the line. Trump BANS China From This One 5G Stock.]( China recently ponied up $1.3 billion for this Portland based company… And President Trump slammed the door shut of the deal. When you see what it’s making, you’ll understand why. [Now the President is committing $275 billion to making sure this company goes big.](  Trend Following Picks  [(ENPH) Buy Target – $24.75 or better]( [(CMRE) Buy Target $8.41 or better]( ([AUY) Buy Target – $3.75 or better]( [(CATB) Buy Target – $5.57 or better]( [(FPAY) – Buy Target – $1.82 or better]( [All Picks]( Reversal Picks  [(PNM) Buy Target $49.43  Sell Target $50.78]( [(SALT) Buy Target $6.32 Sell Target $6.88]( [(RKDA) Buy Target $5.58   Sell Target $6.65]( [(PIRS) Buy Target $4.05 Sell Target $4.79]( [(MGTX) Buy Target $17.29  Sell Target $19.46]( [All Picks](  Already subscribed to our premium service? [Click here to Login]( Not a TradersPro subscriber yet? [Try It Now -  Limited Time Offer](                                --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019